
    
      Open-label, uncontrolled, serial cohort, dose-escalation study evaluating two different
      dosing regimens (Arm 1: cycles of 5 days on drug and 2 days off drug), Arm 2: cycles of 21
      days on drug and 7 days off drug).
    
  